Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJC3B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,484
Award facts
- Contract value 100% obligated
- $36,484.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $36,484 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's comprehensive contract portfolio with the DLA Medical Supply Chain encompasses a wide range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Dupixent—a biologic medication used in immunology and dermatology—exemplifies the company's role in supplying specialized brand-name pharmaceuticals to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FJC3B?
SPE2DR26FJC3B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FJC3B worth?
The government has obligated $36,484 on SPE2DR26FJC3B.
Is contract SPE2DR26FJC3B an order under another contract?
Yes. SPE2DR26FJC3B is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJC3B competed?
The extent of competition for SPE2DR26FJC3B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award